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Mortality and health-related quality
of life in patients surgically treated
for spondylodiscitis
Casper Dragsted1, Theis Aagaard2, Søren Ohrt-Nissen1,
Martin Gehrchen1 and Benny Dahl1
Abstract
Purpose: To assess mortality, disability, and health-related quality of life (HRQL) in patients surgically treated for
spondylodiscitis. Methods: A retrospective longitudinal study was conducted on all patients surgically treated for
spondylodiscitis over a 6-year period at a single tertiary spine center. Indications for surgery, pre- and postoperative
neurological impairment, comorbidities, and mortality were recorded. A survey was conducted on all eligible
patients with the EuroQol 5-dimension (EQ-5D) questionnaire and Oswestry Disability Index (ODI). Results: Sixty-
five patients were diagnosed with spondylodiscitis not related to recent spine surgery. One-year mortality rate was 6%. In
all, 36% and 27% had pre- and postoperative neurological impairment, respectively, with only one patient experiencing
deterioration postoperatively. At final follow-up (median 2 years), mean ODI was 31% (SD ¼ 22) and mean EQ-5D time
trade-off score was 0.639 (SD¼ 0.262); this was significantly lower than that in the normal population (p < 0.001). Patients
with neurological impairment prior to index surgery had lower EQ-5D scores (p ¼ 0.005) and higher ODI (p ¼ 0.02) at
final follow-up compared with patients without neurological impairment. Conclusions: Several years after surgery,
patients surgically treated for spondylodiscitis have significantly lower HRQL and more disability than the background
population. Neurological impairment prior to index surgery predicts adverse outcome in terms of disability and lower
HRQL.
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Introduction
Although it still remains a rare condition, there has been an
increasing incidence of spondylodiscitis over the past
decades.1,2 It is estimated that 20–40% of patients with
spondylodiscitis will undergo surgical treatment.3,4 The
primary indication for surgery is progressive neurological
impairment but indications also include epidural abscess,
pain caused by spinal instability, progressive deformity, or
failure to respond to conservative treatment.5–9 Although
several guidelines have been proposed,7–9 there is no con-
sensus regarding the indications for surgery. Correspond-
ingly, various surgical methods have been described, all
based on varying degrees of debridement of vertebral bod-
ies and discs through anterior, posterior, or combined sur-
gical approaches.5–7,9–12 In most cases, stabilization with
spinal implants is necessary, and in spite of the infectious
nature of the condition, most studies report a low risk of
recurring infection.5,6,10,13,14
The overall mortality of spondylodiscitis is 5–10%,2–4,7,15
but studies reporting outcome after surgical treatment
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are scarce, and few studies have reported the health-related
quality of life (HRQL) after surgery.16–20 A few studies
have shown that a preoperative neurological deficit is a
predictor of a negative outcome,4,8,9 and neurological def-
icits are more often present when the spinal infection
affects the cervical or thoracic regions.8 No studies so far
have examined HRQL in these groups. Such knowledge
would be valuable as an element in establishing guidelines
for the surgical treatment of spondylodiscitis.7 The purpose
of the present study was to assess the mortality, disability,
and HRQL after surgical treatment of spondylodiscitis,
compared to Danish population norm. The primary hypoth-
esis of the study was that HRQL is reduced significantly
1 year after surgical treatment of spondylodiscitis when
compared to the background population.
Material and methods
Study population
A retrospective cohort study was conducted on all patients
undergoing surgical treatment of spondylodiscitis from
January 1, 2005, through December 31, 2010, in a tertiary
referral center serving 2.6 million people. Patients who
had undergone spine surgery for other conditions within
3 months of admission were excluded (Figure 1).
Data analysis
Data collection and analysis were performed using Micro-
soft Excel® 2010 and the statistical software R version
3.3.2. The study was approved by the Danish Data Protec-
tion Agency (J.nr. 2014-41-2820). Data distribution was
assessed with histograms, and continuous variables were
compared using unpaired t test, Wilcoxon rank sum test,
or Kruskal–Wallis analysis. A p value < 0.05 was considered
statistically significant.
Clinical characteristics
Neurological status was assessed retrospectively based on
the surgeon’s preoperative clinical examination using
Frankel’s classification where grade A represents complete
neurological injury and grade E represents normal motor
function. Postsurgical neurological status was assessed at
the latest clinical follow-up. Diagnosis was based on pre-
operative magnetic resonance imaging (MRI) findings, and
in cases of positive microbiology, bacteriological diagnosis
was made from positive blood cultures, needle biopsy, or
surgical sampling. The level of spinal focus was defined as
the level of surgical decompression. A Charlson Comorbid-
ity Index (CCI) score was calculated for each patient,21
indicating the severity of comorbidity, and patients were
grouped into either low (0–1) or high (2) CCI score in line
with other studies.22,23
Surgical procedures
All types of surgical procedures were included (Table 2).
Staged surgery was registered as one single procedure, and
the first operation was recorded as the index surgery. The
primary indication for index surgery was categorized as
one of the following:
– neurological impairment (preoperative Frankel A–D
with or without epidural abscess, deformity, or
instability),
– epidural abscess (Frankel E and epidural abscess
visualized on MRI), and
– instability/deformity (Frankel E and no epidural
abscess, pain, and kyphosis/deformity and/or
instability).
Patients with instability and/or deformity were further
divided into those with ongoing infection and those who
had completed a conservative treatment regime. Compli-
cations to surgery were defined as conditions requiring
Figure 1. Patient flowchart. *Information on neurological status was not available in one patient. **Information on neurological status
was not available on three patients at the latest clinical follow-up.
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unplanned reoperation within 48 h after the index
procedure.
Mortality
Mortality was assessed on December 31, 2011, to allow for
a minimum follow-up of 1 year for all patients. Patients lost
to follow up were recorded as alive based on their last
contact with our department. Patients’ accumulated risk
years from the date of index procedure and mortality were
assessed for all patients at the 1-year mark and for all
accumulated risk years.
Follow-up questionnaires
Patients who were alive and residing in Denmark on
December 31, 2011, were sent two questionnaires by reg-
ular mail: the Danish version of the EuroQol 5-dimension
(EQ-5D) questionnaire and the Oswestry Disability Index
(ODI). HRQL and disability were examined in patients
with and without neurological impairment prior to index
procedure and for different levels of spinal focus. In order
to compare groups, the “time trade-off” (TTO) method24
was used to calculate an index value of the EQ-5D. A post
hoc analysis was performed to further examine possible
associations between EQ-5D/ODI scores and the indica-
tion for surgery, surgical strategy, comorbidity, or the
presence of epidural abscess.
Results
A total of 65 patients were included (Table 1). Staphylo-
coccus aureus was the predominant pathogen (38%) fol-
lowed by Mycobacterium tuberculosis (14%). Eleven
patients (15%) were culture negative. Of these, three
patients were administered antituberculosis medical treat-
ment. However, no positive culture or polymerase chain
reaction was obtained from the blood or tissue sample.
The lumbar spine was the most frequent level of spinal
focus (Table 1). Six patients had more than one focus in the
spine, with the lumbar segments being primarily affected in
all of them. Median time from diagnosis to index surgery
was 4 days (interquartile range [IQR]: 4–34). Patients were
clinically followed up for a median of 134 days (IQR: 25–
455). Prior to the index procedure, 23/64 (36%) had neu-
rological deficits, which were classified as Frankel D or
lower. At the latest clinical follow-up, 17/62 (27%) had
neurological deficits. Overall, 12/23 (52%) with preopera-
tive neurological impairment improved by one or two Fran-
kel categories during the study period (Figure 2). One
patient experienced neurological deterioration, from Fran-
kel category D to C due to a postoperative intraspinal
hematoma. Neurological status was not assessed in one
patient prior to index surgery and in three patients at the
latest clinical follow-up due to the lack of information in
the patient files.
Surgery
A total of 79 surgical procedures for spondylodiscitis were
performed in the 65 patients (Table 2). In 15 patients,
indication for surgery was instability and/or deformity,
and 5 (8%) of these had completed a conservative treat-
ment regime and showed no sign of ongoing infection, and
surgical biopsies were all culture negative. Median time
from diagnosis to index surgery was 384 days (range:
Table 1. Baseline characteristics of patients surgically treated for
spondylodiscitis.
Variable No. (%)




Age at index surgerya 60 (51–70)
Comorbidities and risk factors 45/65 (69)
Alcohol abuse 17 (26)
Diabetes mellitus 16 (25)
Immunocompromisedb 7 (11)
COPDc 7 (11)
IV drug abuse 6 (9)
Renal failure 5 (8)
Congestive heart failure 4 (6)
Liver cirrhosis 3 (5)
IBD 3 (5)
Disseminated cancer 2 (3)
Rheumatic disease 2 (3)
Chronic viral hepatitis 2 (3)
Cancer without metastasis 1 (2)
Endocarditis 1 (2)
Microbiological diagnosis
Staphylococcus aureus 28 (38)
Mycobacterium tuberculosis 9 (14)
Enterobacteriaed 6 (9)
Coagulase neg. Staphylococci 4 (6)
Streptococci (oralis and bovis) 2 (3)
Atypical mycobacteriae 1 (2)
MRSAe 1 (2)
Haemophilus aphrophilus 1 (2)
Listeria monocytogenes 1 (2)
Pseudomonas aeruginosa 1 (2)
Polymicrobielf 1 (2)
None 10 (15)





Multifocal involvement of the spine 6 (8)
Psoas abscess 23 (35)
Epidural abscess 46 (71)
IBD: inflammatory bowel disease.
aMedian (interquartile range).
bChemotherapy, steroid treatment, or immunodeficiency.
cChronic obstructive pulmonary disease.
dEscherichia coli (3), Enterococcus faecalis (2), Veillonella (1).
eMethicillin-resistant Staphylococcus aureus.
fCitrobacter and Enterococcus faecium.
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145–1438) in this group. Six patients had surgical drai-
nage of psoas abscess performed in an isolated procedure
at some point of their disease. Five patients developed
postoperative complications requiring revision surgery.
All five patients were primarily operated with posterior
decompression. The indication for revision surgery was
neurological deterioration and intraspinal hematomas
diagnosed on MRI within 48 h of surgery. Of the 65
patients, 13 (20%) underwent reoperation, not including
the 5 revision procedures due to complications. Four of
these 13 patients had posterior decompression performed
as index surgery and underwent an additional spinal
procedure with posterior instrumentation.
Mortality and follow-up
The 1-year crude mortality rate was 6.5%. Patients accu-
mulated a total of 185 person-years of observation for mor-
tality (median 2 years). Overall mortality was 12/65 (18%)
in this period. At final follow-up, a total of 13 patients had
died (1 patient died after assessing mortality but before
receiving follow-up questionnaires), and 9 patients could
not be located, primarily due to emigration. The remaining
43 patients received the EQ-5D questionnaire and ODI
median 2 years after their index procedure (IQR: 1.2–4.9
years) of which 32 (74%) answered both questionnaires. On
the EQ-5D visual analog scale, the mean health status was
59 (SD¼ 21) on a scale from 0 to 100, where 0 is the worst
possible health. The mean TTO score of the patients in our
study (0.639, SD¼ 0.262) was significantly lower than that
of a Danish age- and sex-matched normal population (p <
0.0001).24 The median ODI score was 29 (IQR: 18–44),
where a score of 0 corresponds to no disability at all. Only
preoperative neurological impairment was a predictor of
adverse outcome, with significantly lower EQ-5D and
higher ODI scores at follow-up in this group (Table 3).
Additionally, we found significant differences in ODI and
EQ-5D scores between the three indication categories
(p ¼ 0.027 and p ¼ 0.036, respectively; Figure 3).
Discussion
In the present study, the HRQLwas significantly reduced in
patients surgically treated for spondylodiscitis compared
with the population norm. Preoperative neurological
impairment was identified as a negative predictor of
HRQL, despite neurology improvement in most patients.
The primary strength of the present study is that it is a
one-center study with a high number of patients compared
with other studies of surgical treatment of spondylodiscitis.
Baseline characteristics did not differ significantly from
other studies of patients with spondylodiscitis undergoing
surgical as well as conservative treatment.3,5,6,10,12,16,19,25
A considerable number of patients had comorbidities con-
sistent with the literature.3,4,8,15 The predominant pathogen
was S. aureus, but in a large number of patients no
Figure 2. Neurological status prior to index surgery (preop) and
at the latest clinical follow-up (postop) according to the Frankel
classification. *Information on neurological status was not avail-
able for one patient. **Information on neurological status was not
available for three patients at latest clinical follow-up.
Table 2. Surgical approach of the 79 spinal procedures for
spondylodiscitis performed in 65 patients.
Total number of patients No. ¼ 65
Total number of spinal procedures 79
Complications to spinal procedures 5 (6%)
Index procedure surgical approach
Anterior decompression 3 (4%)
Anterior decompression and instrumentation 9 (13%)
Posterior decompression 29 (41%)
Posterior decompression and instrumentation 11 (16%)
Combined two-stage anterior and posterior
instrumentation
13 (19%)
Indications for index surgery
Neurological impairment 23 (35%)
Epidural abscess 27 (42%)
Deformity/instability 15 (23%)
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microbiological diagnosis could be established in accor-
dance with the literature.3,4
Most studies report overall mortality, even though this
strongly correlates to the length of follow-up.15 The 1-year
crude mortality rate in our study was comparable with the
4.8% reported by Woertgen et al.,16 but less than a recent
large-scale registry study on a Danish population.15 The high
mortality rate (20%) in the latter study was possibly due to
an older study population and inclusion of patients who were
too critically ill to be referred to a tertiary hospital. A nation-
wide study of spondylodiscitis by Aagaard et al. showed a 1-
year crude mortality rate of 5.6%.22 By including only
patients with S. aureus bacteremia, the increased mortality
compared with a background population was shown to be
mainly due to comorbidities. Overall, there is no evidence of
increased mortality in surgically treated spondylodiscitis
patients compared with those treated conservatively.4,8,15,16
The high rate of mortality and morbidity seen in spon-
dylodiscitis patients is likely multifactorial. Our study did
not find an association between CCI score and adverse
morbidity outcome (Table 3). This may be due to a type
2 error since the high CCI group included only 15 patients;
however, the CCI represents only 1-year mortality and
not necessarily HRQL and disability. Additionally, the
small number of patients limited our subgroup analysis to
include only EQ-5D and ODI scores rather than mortality
as outcome measure.
In the present study, neurological status was assessed
retrospectively based on the latest clinical follow-up, with
significant variation in the length of this period. In all, 36%
of patients had neurological impairment at the time of their
index procedure (Figure 1). This is comparable to the
results reported in the literature, ranging from 27 to 56%
in studies of surgically treated patients5,6,12,25,26 and 17–27%
in conservatively treated patients.3,4,8 Overall 52% of
patients with preoperative neurological impairment
improved by one or two Frankel grades (Figure 2). Although
this number might have increased with longer clinical
follow-up for some patients, it is slightly higher compared
to another Danish study12 where only 45% improved in
neurological status, whereas other studies have shown
improvement in neurological impairment in 80–87% of
cases.5,6 However, these studies differed from our study as
all patients underwent a combined anterior–posterior proce-
dure. Obviously, patient selection affects the preoperative
neurological status, and comparison of studies with different
surgical strategies can therefore be challenging.
To evaluate HRQL and disability, the EQ-5D and the
ODI questionnaires were chosen. EQ-5D is a general
health questionnaire with a limited number of questions,
and the possibility to compare an overall score with results
from various other populations, as well as the background
population.24,27 Since no disease-specific questionnaire
exists regarding spondylodiscitis, we chose the ODI, a
disease-specific questionnaire for patients with chronic
low back pain (CLBP), which has been widely used in the
evaluation of surgical outcome in other spondylodiscitis
studies.27
Table 3. EQ-5D “TTO” and ODI scores at minimum 1-year follow-up.
Group
EQ-5D TTO-score ODI
n Median (IQR) Difference Median (IQR) Difference
Level of spinal focus
Thoracic/cervical 18 0.682 (0.584–0.734) p ¼ 0.338 26 (19–53) p ¼ 0.845
Lumbar/thoracolumbar 47 0.723 (0.520–0.783) 28 (18–41)
Neurological impairment preoperative
Yes (Frankel A–D) 23 0.592 (0.367–0.660) p ¼ 0.011b 38 (30–63) p ¼ 0.034b
No (Frankel E) 41a 0.742 (0.658–0.805) 24 (14–33)
Index surgical approach
Instrumentation1 33 0.723 (0.609–0.774) p ¼ 0.791 30 (22–44) p ¼ 0.458
No instrumentation2 32 0.660 (0.367–0.776) 22 (18–37)
Comorbidity
Low Charlson score (0–1) 50 0.723 (0.592–0.776) p ¼ 0.599 29 (18–42) p ¼ 0.826
High Charlson score (2) 15 0.660 (0.463–0.774) 22 (20–48)
Epidural abscess
Present 46 0.660 (0.367–0.776) p ¼ 0.606 24 (18–54) p ¼ 0.371
Not present 19 0.723 (0.684–0.776) 30 (24–38)
Psoas abscess
Present 23 0.689 (0.333–0.783) p ¼ 0.760 18 (17–49) p ¼ 0.528
Not present 42 0.716 (0.609–0.775) 30 (19–42)
IQR: interquartile range; 1: Anterior, posterior or combined decompression and instrumentation; 2: Isolated anterior or posterior decompression only;
TTO: time trade-off; ODI: Oswestry Disability Index; EQ-5D: EuroQol 5-dimension
aInformation on neurological status was not available in one patient.
bp < 0.05 was considered statistically significant using Wilcoxon rank sum test.
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Based on the mean EQ-5D TTO scores, the HRQL was
significantly lower in spondylodiscitis patients compared
with a normal Danish population of similar age and
gender24 (Table 3). This is in line with the results shown
by Woertgen et al.16 using the Short-Form 36 (SF-36)
health survey. They also suggested a slightly better out-
come in patients treated surgically than those treated con-
servatively. We identified only one prospective
randomized trial by Linhardt et al., assessing HRQL and
disability in 22 patients by comparing anterior surgery with
a combined anterior–posterior procedure.19 Overall, better
outcome was found in the group with an anterior-only
approach, using the SF-36 and ODI, 2 and 5 years after
surgery. ODI scores for the group with a combined ante-
rior–posterior procedure were comparable with the average
score in our study; but in the group undergoing anterior
surgery, the ODI score was much lower and the SF-36
scores even better than that in a healthy population.
Overall, the ODI score in our study was comparable to
other studies with scores ranging from 23 to 30.11,19,20,25 It
has previously been shown that neurological impairment is
a risk factor for adverse outcome in terms of recurrent
infection and increased short-term mortality.9,15 Our study
confirmed that preoperative neurological impairment is a
predictor of adverse outcome in terms of higher disability
and lower HRQL (Table 3). Some studies suggest that neu-
rologic deficits are more common when the disease
involves cervical and thoracic levels of the spine.4,8 How-
ever, no difference was found with regard to the level of
spinal focus in the current study. We identified two former
studies assessing EQ-5D in selected spondylodiscitis
patients treated surgically; however, these studies exam-
ined selected surgical strategies and included only eight
and 27 patients, respectively.18,20
The literature on surgical treatment of spondylodiscitis
generally supports stabilization of the infected levels with
spinal instrumentation.5,7,9,12,13,16 Four patients in our
study underwent an isolated posterior decompression as
index surgery but later underwent reoperation with instru-
mentation. Moreover, all five patients with complications
underwent posterior decompression as index surgery. A
post hoc analysis however showed no difference in HRQL
and disability between instrumented and uninstrumented
cases (Table 3), although this result could be biased by
patient selection as the decompression group possibly had
less extensive disease at baseline.
Figure 3. Box plot of the association between EuroQol 5-dimension (EQ-5D) and Oswestry Disability Index (ODI) scores at follow-up
and primary indication for index surgery. Kruskal–Wallis analysis with significant differences in ODI score (p¼ 0.027) and EQ-5D score
(p ¼ 0.036) between the three indication categories.
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The primary limitation of the present study is its
retrospective design. This could especially affect the clas-
sification of neurological impairment. However, the pri-
mary focus of the study was the comparison of HRQL
with the normal population and not the detailed neurologic
outcome. Since the majority of variables of the patient
population correspond to results in the literature, we find
that the results regarding HRQL are representative of
patients with surgically treated spondylodiscitis and not
related to a specific procedure. Although a higher response
rate would be desirable, we find that the 74% response rate
is acceptable for this heterogenic population and in line
with previous studies with a similar design.16,17
Conclusion
To our knowledge, this is the largest study assessing HRQL
with EQ-5D after surgical treatment of spondylodiscitis.
The HRQL was significantly lower than that in a normal
population of similar age and gender. Finally, preoperative
neurological impairment predicted adverse outcome
despite neurological improvements after surgery. Our find-
ings may aid future studies in determining which patients
would benefit from surgery when compared with conser-
vative treatment.
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